The EuroFlow™ strategy to monitor minimal residual disease (MRD) by Next Generation Flow has been focused in B-cell precursor (BCP) acute lymphoblastic leukemia (ALL) patients.

The BCP-ALL MRD kit, designed following the fully-standardized EuroFlow™ 8-color antibody panel, allows measuring MRD and discriminating between normal and malignant BCP cells in 99% of studied BCP-ALL patients.

Protected by patent.

Pacific Blue™ is a trademark of Life Technologies Corporation

This product should be used in combination with the EuroFlow™ Standard Operation Procedures for instrument setup:

  • The “EuroFlow SOP for instrument set-up and compensation for BD LSR II and BD FACS Canto II. Version 2.0 – February 2025” can be downloaded here.
  • The “EuroFlow SOP for instrument set-up and compensation for BD Lyric for 8-color panels. Version 2.0 – June 2025” can be downloaded here.